<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Naltrexone</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Naltrexone">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Naltrexone</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Naltrexone</b>, sold under the brand names <b>ReVia</b> and <b>Vivitrol</b> among others, is a medication primarily used to manage alcohol or opioid dependence.<span class="mw-ref" id="cite_ref-AHFS2017_1-0"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> An opioid-dependent person should not receive naltrexone before detoxification.<span class="mw-ref" id="cite_ref-AHFS2017_1-1"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is taken by mouth or by injection into a muscle.<span class="mw-ref" id="cite_ref-AHFS2017_1-2"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Effects begin within 30 minutes.<span class="mw-ref" id="cite_ref-AHFS2017_1-3"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> A decreased desire for opioids, though, may take a few weeks.<span class="mw-ref" id="cite_ref-AHFS2017_1-4"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<div role="note" class="hatnote navigation-not-searchable">Not to be confused with <a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a> or Nalmexone.</div>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Naltrexone</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Naltrexone_skeletal.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Naltrexone_skeletal.svg.png" data-file-width="516" data-file-height="500" data-file-type="drawing" height="194" width="200"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Naltrexone-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Naltrexone-3D-balls.png" data-file-width="1100" data-file-height="722" data-file-type="bitmap" height="164" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>ˌ</span><span>n</span><span>æ</span><span>l</span><span>ˈ</span><span>t</span><span>r</span><span>ɛ</span><span>k</span><span>s</span><span>oʊ</span><span>n</span></span>/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>ReVia, Vivitrol, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>EN-1639A; UM-792; <i>N</i>-Cyclopropyl-methylnoroxymorphone; <i>N</i>-Cyclopropylmethyl-14-hydroxydihydro-morphinone; 17-(Cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/naltrexone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/naltrexone.html'" tppabs="https://www.drugs.com/monograph/naltrexone.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a685041.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a685041.html'" tppabs="https://medlineplus.gov/druginfo/meds/a685041.html" class="external text external">a685041</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Naltrexone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Naltrexone'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Naltrexone" class="external text external">Naltrexone</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, intramuscular injection, subcutaneous implant</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N07BB04<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N07BB04  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N07BB04'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N07BB04" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>5–40%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>21%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>Naltrexone: 4 hours<br>6β-Naltrexol: 13 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1<i>H</i>-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=16590-41-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=16590-41-3'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=16590-41-3" class="external text external">16590-41-3</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5360515  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5360515'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5360515" class="external text external">5360515</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1639'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1639" class="external text external">1639</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00704  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00704'" tppabs="https://www.drugbank.ca/drugs/DB00704" class="external text external">DB00704</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4514524.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4514524.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4514524.html" class="external text external">4514524</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=5S6W795CQM  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=5S6W795CQM'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=5S6W795CQM" class="external text external">5S6W795CQM</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D05113  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D05113'" tppabs="https://www.kegg.jp/entry/D05113" class="external text external">D05113</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7465  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7465'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7465" class="external text external">CHEBI:7465</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL19019  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL19019'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL19019" class="external text external">ChEMBL19019</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID4046313  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID4046313'" tppabs="https://comptox.epa.gov/dashboard/DTXSID4046313" class="external text external">DTXSID4046313</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.036.939  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.036.939'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.036.939" class="external text external">100.036.939</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>20</sub><span>H</span><sub>23</sub><span>N</span><span>O</span><sub>4</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">341.407</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC4%5BC%40%40H%5D5Oc1c2c%28ccc1O%29C%5BC%40H%5D3N%28CC%5BC%40%5D25%5BC%40%40%5D3%28O%29CC4%29CC6CC6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC4%5BC%40%40H%5D5Oc1c2c%28ccc1O%29C%5BC%40H%5D3N%28CC%5BC%40%5D25%5BC%40%40%5D3%28O%29CC4%29CC6CC6'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC4%5BC%40%40H%5D5Oc1c2c%28ccc1O%29C%5BC%40H%5D3N%28CC%5BC%40%5D25%5BC%40%40%5D3%28O%29CC4%29CC6CC6" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>169<span>&nbsp;</span>°C (336<span>&nbsp;</span>°F)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C4[C@@H]5Oc1c2c(ccc1O)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)CC6CC6</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:DQCKKXVULJGBQN-XFWGSAIBSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464372546&page2=Naltrexone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464372546&page2=Naltrexone'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464372546&page2=Naltrexone" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Side effects may include trouble sleeping, anxiety, nausea, and headaches.<span class="mw-ref" id="cite_ref-AHFS2017_1-5"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> In those still on opioids, opioid withdrawal may occur.<span class="mw-ref" id="cite_ref-AHFS2017_1-6"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Use is not recommended in people with liver failure.<span class="mw-ref" id="cite_ref-AHFS2017_1-7"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is unclear if use is safe during pregnancy.<span class="mw-ref" id="cite_ref-AHFS2017_1-8"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Naltrexone is an opioid antagonist and works by blocking the effects of opioids, both those from inside and outside the body.<span class="mw-ref" id="cite_ref-AHFS2017_1-9"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>
Naltrexone was first made in 1965 and was approved for medical use in the United States in 1984.<span class="mw-ref" id="cite_ref-AHFS2017_1-10"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Sad2012_3-0"><a href="#cite_note-Sad2012-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Naltrexone, as naltrexone/bupropion, is also used to treat obesity.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style></p><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Alcoholism">Alcoholism</h3></summary>
    
<p>Naltrexone has been best studied as a treatment for alcoholism.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Naltrexone has been shown to decrease the amount and frequency of drinking.<span class="mw-ref" id="cite_ref-Ros2010_6-0"><a href="#cite_note-Ros2010-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It does not appear to change the percentage of people drinking.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Its overall benefit has been described as "modest".<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p><a href="Acamprosate.htm" tppabs="https://ptable.com/wiki/compounds/A/Acamprosate" title="Acamprosate">Acamprosate</a> may work better than naltrexone for eliminating drinking, while naltrexone may decrease the desire for alcohol to a greater extent.<span class="mw-ref" id="cite_ref-Mai2013_9-0"><a href="#cite_note-Mai2013-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>

<p>The Sinclair method is a method of using opiate antagonists such as naltrexone to treat alcoholism. The person takes the medication about an hour (and only then) before drinking to avoid side effects that arise from chronic use.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Sin2001_11-0"><a href="#cite_note-Sin2001-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> The opioid antagonist blocks the positive-reinforcement effects of alcohol and allows the person to stop or reduce drinking.<span class="mw-ref" id="cite_ref-Sin2001_11-1"><a href="#cite_note-Sin2001-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Opioid_use">Opioid use</h3></summary>
    
<p>Long-acting injectable naltrexone decreases <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a> use more than placebo.<span class="mw-ref" id="cite_ref-Shar2017_12-0"><a href="#cite_note-Shar2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> It has benefits over <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a> and <a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">buprenorphine</a> in that it is not a restricted medication.<span class="mw-ref" id="cite_ref-Shar2017_12-1"><a href="#cite_note-Shar2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> It may decrease cravings for opioids after a number of weeks, and decreases the risk of overdose, at least during the time period that naltrexone is still active.<span class="mw-ref" id="cite_ref-AHFS2017_1-11"><a href="#cite_note-AHFS2017-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> It is given once per month and has better compliance than the oral formulation.<span class="mw-ref" id="cite_ref-ComerSullivan2006_14-0"><a href="#cite_note-ComerSullivan2006-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>A 2011 review found insufficient evidence to determine the effect of naltrexone taken by mouth in opioid dependence.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> While some do well with this formulation, it must be taken daily, and a person whose cravings become overwhelming can obtain opioid intoxication simply by skipping a dose. Due to this issue, the usefulness of oral naltrexone in opioid use disorders is limited by the low retention in treatment. Naltrexone by mouth remains an ideal treatment for a small number of people with opioid use, usually those with a stable social situation and motivation. With additional contingency management support, naltrexone may be effective in a broader population.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Others">Others</h3></summary>
    
<p>Naltrexone is not useful for quitting smoking.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Low-dose naltrexone has been used in chronic pain such as fibromyalgia with tentative evidence of benefit.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>Naltrexone is available and most commonly used in the form of an oral tablet (50<span>&nbsp;</span>mg).<span class="mw-ref" id="cite_ref-Milhorn2017_20-0"><a href="#cite_note-Milhorn2017-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Vivitrol, a naltrexone formulation for depot injection containing 380<span>&nbsp;</span>mg of the medication per vial, is also available.<span class="mw-ref" id="cite_ref-Milhorn2017_20-1"><a href="#cite_note-Milhorn2017-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-MedicalNewsToday2006_21-0"><a href="#cite_note-MedicalNewsToday2006-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Additionally, naltrexone subcutaneous implants that are surgically implanted are available.<span class="mw-ref" id="cite_ref-TGA_22-0"><a href="#cite_note-TGA-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> While these are manufactured in Australia, they are not authorized for use within Australia, but only for export.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> By 2009, naltrexone implants showed encouraging results.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Naltrexone should not be used by persons with acute hepatitis or liver failure, or those with recent opioid use (typically 7–10 days).</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>The most common side effects reported with naltrexone are gastrointestinal complaints such as diarrhea and abdominal cramping. These adverse effects are analogous to the symptoms of opioid withdrawal, as the mu receptor blockade will increase GI motility.</p>

<p>Naltrexone has been reported to cause liver damage (when given at doses higher than recommended). It carries an FDA boxed warning for this rare side effect. Due to these reports, some physicians may check liver function tests prior to starting naltrexone, and periodically thereafter. Concerns for liver toxicity initially arose from a study of nonaddicted obese patients receiving 300<span>&nbsp;</span>mg of naltrexone.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Subsequent studies have suggested limited toxicity in other patient populations.</p>

<p>Naltrexone should not be started until several (typically 7-10) days of abstinence from opioids have been achieved. This is due to the risk of acute opioid withdrawal if naltrexone is taken, as naltrexone will displace most opioids from their receptors. The time of abstinence may be shorter than 7 days, depending on the half-life of the specific opioid taken. Some physicians use a naloxone challenge to determine whether an individual has any opioids remaining. The challenge involves giving a test dose of naloxone and monitoring for opioid withdrawal. If withdrawal occurs, naltrexone should not be started.<span class="mw-ref" id="cite_ref-galanter_26-0"><a href="#cite_note-galanter-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<table class="wikitable floatright" style="text-align: center;">
<caption>Naltrexone at opioid receptors</caption>
<tbody><tr>
<th colspan="3">Affinities (<abbr>K<sub>i</sub></abbr>)</th><th>Ratio</th><th rowspan="2">Ref</th></tr>
<tr>
<th><abbr>MOR</abbr></th><th><abbr>DOR</abbr></th><th><abbr>KOR</abbr></th><th>MOR:DOR:KOR</th></tr>
<tr>
<td>1.0 nM<br>0.0825 nM</td><td>149 nM<br>8.02 nM</td><td>3.9 nM<br>0.509 nM</td><td>1:149:4<br>1:97:6</td><td><span class="mw-ref" id="cite_ref-pmid8114680_27-0"><a href="#cite_note-pmid8114680-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><br><span class="mw-ref" id="cite_ref-pmid7562497_28-0"><a href="#cite_note-pmid7562497-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></td></tr>
</tbody></table>

<p>Naltrexone and its active metabolite 6β-naltrexol are competitive antagonists at the μ-opioid receptor (MOR), the κ-opioid receptor (KOR) to a lesser extent, and, to a far lesser extent, at the δ-opioid receptor (DOR).<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Mechanism_of_action">Mechanism of action</h4></summary>
    
<p>The blockade of opioid receptors is the basis behind naltrexone's action in the management of opioid dependence<span>—</span>it reversibly blocks or attenuates the effects of opioids. Its mechanism of action in alcohol dependence is generated via κ-opioid receptor antagonism,<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> which blocks the actions of the endogenous opioid peptide dynorphin.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> Dynorphin typically instates drug-seeking behavior when it binds to the κ-opioid receptor, as well as decreasing dopaminergic signalling in the nucleus accumbens.<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Naltrexone is metabolized in the liver mainly to 6β-naltrexol by the enzyme dihydrodiol dehydrogenase. Other metabolites include 2-hydroxy-3-methoxy-6β-naltrexol and 2-hydroxy-3-methoxy-naltrexone. These are then further metabolized by conjugation with glucuronide. The plasma half-life of naltrexone and its metabolite 6β-naltrexol are about 4 hours and 13 hours, respectively.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacogenetics">Pharmacogenetics</h3></summary>
    
<p>Tentative evidence suggests that family history and presence of the Asn40Asp polymorphism predicts naltrexone being effective.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>Naltrexone can be described as a substituted <a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">oxymorphone</a> <span>–</span> here the tertiary amine methyl-substituent is replaced with <a href="Methylcyclopropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylcyclopropane" title="Methylcyclopropane">methylcyclopropane</a>. Naltrexone is the N-cyclopropylmethyl derivative of oxymorphone.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Analogues">Analogues</h3></summary>
    
<p>The closely related medication, methylnaltrexone, is used to treat opioid-induced constipation, but does not treat addiction as it does not cross the blood–brain barrier. <a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a> is similar to naltrexone and is used for the same purposes as naltrexone. Naltrexone should not be confused with <a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">naloxone</a>, which is used in emergency cases of opioid overdose. Other related opioid antagonists include nalodeine and samidorphan.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Naltrexone was first synthesized in 1963 by Metossian at Endo Laboratories, a small pharmaceutical company in New York City.<span class="mw-ref" id="cite_ref-Dependence1974_35-0"><a href="#cite_note-Dependence1974-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> It was characterized by Blumberg, Dayton, and Wolf in 1965 and was found to be an orally active, long-acting, and very potent opioid antagonist.<span class="mw-ref" id="cite_ref-Dependence1974_35-1"><a href="#cite_note-Dependence1974-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-PadwaCunningham2010_36-0"><a href="#cite_note-PadwaCunningham2010-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-Bennett2004_37-0"><a href="#cite_note-Bennett2004-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-Sad2012_3-1"><a href="#cite_note-Sad2012-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The drug showed advantages over earlier opioid antagonists such as <a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">cyclazocine</a>, <a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">nalorphine</a>, and naloxone, including its oral activity, a long duration of action allowing for once-daily administration, and a lack of dysphoria, and was selected for further development.<span class="mw-ref" id="cite_ref-Sad2012_3-2"><a href="#cite_note-Sad2012-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It was patented by Endo Laboratories in 1967 under the developmental code name EN-1639A and Endo Laboratories was acquired by DuPont in 1969.<span class="mw-ref" id="cite_ref-Wouk2009_38-0"><a href="#cite_note-Wouk2009-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Clinical trials for opioid dependence began in 1973, and a developmental collaboration of DuPont with the National Institute on Drug Abuse  for this indication started the next year in 1974.<span class="mw-ref" id="cite_ref-Wouk2009_38-1"><a href="#cite_note-Wouk2009-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> The drug was approved by the FDA for the oral treatment of opioid dependence in 1984, with the brand name Trexan, and for the oral treatment of alcohol dependence in 1995, when the brand name was changed by DuPont to ReVia.<span class="mw-ref" id="cite_ref-Wouk2009_38-2"><a href="#cite_note-Wouk2009-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><span class="mw-ref" id="cite_ref-Milhorn2017_20-2"><a href="#cite_note-Milhorn2017-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> A depot formulation for intramuscular injection was approved by the FDA under the brand name Vivitrol for alcohol dependence in 2006 and opioid dependence in 2010.<span class="mw-ref" id="cite_ref-MedicalNewsToday2006_21-1"><a href="#cite_note-MedicalNewsToday2006-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-Milhorn2017_20-3"><a href="#cite_note-Milhorn2017-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generic_names">Generic names</h3></summary>
    
<p>Naltrexone is the generic name of the drug and its <abbr>INN</abbr>, <abbr>USAN</abbr>, <abbr>BAN</abbr>, <abbr>DCF</abbr>, and <abbr>DCIT</abbr>, while naltrexone hydrochloride is its <abbr>USP</abbr> and <abbr>BANM</abbr>.<span class="mw-ref" id="cite_ref-Elks2014_39-0"><a href="#cite_note-Elks2014-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_40-0"><a href="#cite_note-IndexNominum2000-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall2012_41-0"><a href="#cite_note-MortonHall2012-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_42-0"><a href="#cite_note-Drugs.com-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Naltrexone is or has been marketed under a variety of brand names, including Adepend, Antaxone, Celupan, Depade, Nalorex, Narcoral, Nemexin, Nodict, Revia/ReVia, Trexan, and Vivitrol.<span class="mw-ref" id="cite_ref-Elks2014_39-1"><a href="#cite_note-Elks2014-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_40-1"><a href="#cite_note-IndexNominum2000-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall2012_41-1"><a href="#cite_note-MortonHall2012-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_42-1"><a href="#cite_note-Drugs.com-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> It is also marketed in combination with <a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">bupropion</a> (naltrexone/bupropion) as Contrave and Mysimbam, and was marketed with <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a> (morphine/naltrexone) as Embeda.<span class="mw-ref" id="cite_ref-Drugs.com_42-2"><a href="#cite_note-Drugs.com-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> A combination of naltrexone with <a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">buprenorphine</a> (buprenorphine/naltrexone) has been developed, but has not been marketed.<span class="mw-ref" id="cite_ref-pmid18212797_43-0"><a href="#cite_note-pmid18212797-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Controversies">Controversies</h3></summary>
    

<p>The FDA authorized use of injectable naltrexone for opioid addiction using a single study<span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> that was led by Evgeny Krupitsky at Bekhterev Research Psychoneurological Institute, St Petersburg State Pavlov Medical University, St Petersburg, Russia,<span class="mw-ref" id="cite_ref-Lancet_Krupitsky_2011_naltrexone_45-0"><a href="#cite_note-Lancet_Krupitsky_2011_naltrexone-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> a country where opioid agonists such as methadone and buprenorphine are not available. The study was a "double-blind, placebo-controlled, randomized", 24-week trial running "from July 3, 2008, through October 5, 2009" with "250 patients with opioid dependence disorder" at "13 clinical sites in Russia" on the use of injectable naltrexone (XR-NTX) for opioid dependence. The study was funded by the Boston-based biotech Alkermes firm which produces and markets naltrexone in the United States.  A 2011 article reported that this single trial of naltrexone was performed not by comparing it to the best available, evidence-based treatment (methadone or buprenorphine), but by comparing it with a placebo.<span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> A subsequent RCT in Norway did compare injectable naltrexone to buprenorphine and found them to be similar in outcomes.<span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>

<p>In May 2017, United States Secretary of Health and Human Services Tom Price, praised [Vivitrol] as the future of opioid addiction treatment after visiting the company's plant in Ohio.<span class="mw-ref" id="cite_ref-NYT_2017_Vivitrol_48-0"><a href="#cite_note-NYT_2017_Vivitrol-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> His remarks set off sharp criticism with almost 700 experts in the field of substance abuse submitting a letter to Price cautioning him about Vivitrol's "marketing tactics" and warning him that his comment "ignore widely accepted science".<span class="mw-ref" id="cite_ref-Tom-Price-Letter-Re-MAT_2017_49-0"><a href="#cite_note-Tom-Price-Letter-Re-MAT_2017-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> The experts pointed out that Vivitrol's competitors, buprenorphine and methadone, are "less expensive", "more widely used", and have been "rigorously studied".</p>

<p>Price had claimed that buprenorphine and methadone were "simply substitute[s]" for "illicit drugs"<span class="mw-ref" id="cite_ref-NYT_2017_Vivitrol_48-1"><a href="#cite_note-NYT_2017_Vivitrol-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> whereas according to the letter, "the substantial body of research evidence supporting these treatments is summarized in guidance from within your own agency, including the Substance Abuse and Mental Health Services Administration, the US Surgeon General, the National Institute on Drug Abuse, and the Centers for Disease Control and Prevention. To briefly summarize, buprenorphine and methadone have been demonstrated to be highly effective in managing the core symptoms of opioid use disorder, reducing the risk of relapse and fatal overdose, and encouraging long-term recovery."<span class="mw-ref" id="cite_ref-Tom-Price-Letter-Re-MAT_2017_49-1"><a href="#cite_note-Tom-Price-Letter-Re-MAT_2017-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p>

<p>According to a June 11, 2017, <i>The New York Times</i> article, Alkermes "has spent years coaxing, with a deft lobbying strategy that has targeted lawmakers and law enforcement officials. The company has spent millions of dollars on contributions to officials struggling to stem the epidemic of opioid abuse. It has also provided thousands of free doses to encourage the use of Vivitrol in jails and prisons, which have by default become major detox centers".<span class="mw-ref" id="cite_ref-NYT_2017_Vivitrol_48-2"><a href="#cite_note-NYT_2017_Vivitrol-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Depersonalization">Depersonalization</h3></summary>
    
<p>Naltrexone is sometimes used in the treatment of dissociative symptoms such as depersonalization and derealization.<span class="mw-ref" id="cite_ref-SimeonAbugel2008_50-0"><a href="#cite_note-SimeonAbugel2008-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-PhDPhD2014_51-0"><a href="#cite_note-PhDPhD2014-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> Some studies suggest it might help.<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> Other small, preliminary studies have also shown benefit.<span class="mw-ref" id="cite_ref-SimeonAbugel2008_50-1"><a href="#cite_note-SimeonAbugel2008-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-PhDPhD2014_51-1"><a href="#cite_note-PhDPhD2014-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> Blockade of the KOR by naltrexone and naloxone is thought to be responsible for their effectiveness in ameliorating depersonalization and derealization.<span class="mw-ref" id="cite_ref-SimeonAbugel2008_50-2"><a href="#cite_note-SimeonAbugel2008-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-PhDPhD2014_51-2"><a href="#cite_note-PhDPhD2014-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> Since these drugs are less efficacious in blocking the KOR relative to the MOR, higher doses than typically used seem to be necessary.<span class="mw-ref" id="cite_ref-SimeonAbugel2008_50-3"><a href="#cite_note-SimeonAbugel2008-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-PhDPhD2014_51-3"><a href="#cite_note-PhDPhD2014-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Low-dose">Low-dose</h3></summary>
    

<p>"Low-dose naltrexone" (LDN) describes the "off-label" use of naltrexone at low doses for diseases not related to chemical dependency or intoxication, such as multiple sclerosis.<span class="mw-ref" id="cite_ref-Novella_53-0"><a href="#cite_note-Novella-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> More research needs to be done before it can be recommended for clinical use.</p>

<p>Although some scientific studies show its efficacy in some conditions such as fibromyalgia,<span class="mw-ref" id="cite_ref-ldntxfm_54-0"><a href="#cite_note-ldntxfm-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> other, more dramatic claims for its use in conditions such as cancer and HIV have less scientific support.<span class="mw-ref" id="cite_ref-Novella_53-1"><a href="#cite_note-Novella-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> This treatment has received significant attention on the Internet, especially through websites run by organizations promoting its use.<span class="mw-ref" id="cite_ref-NMSS_55-0"><a href="#cite_note-NMSS-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Self-injury">Self-injury</h3></summary>
    
<p>One study suggests that self-injurious behaviors present in persons with developmental disabilities (including autism) can sometimes be remedied with naltrexone.<span class="mw-ref" id="cite_ref-56"><a href="#cite_note-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span>
In these cases,  the self-injury is believed to be done to release beta-endorphin, which binds to the same receptors as heroin and morphine.<span class="mw-ref" id="cite_ref-57"><a href="#cite_note-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> If the "rush" generated by self-injury is removed, the behavior may stop.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Behavioral_disorders">Behavioral disorders</h3></summary>
    
<p>Some indications exist that naltrexone might be beneficial in the treatment of impulse-control disorders such as kleptomania, compulsive gambling, or trichotillomania (compulsive hair pulling), but  evidence of its effectiveness for gambling is conflicting.<span class="mw-ref" id="cite_ref-58"><a href="#cite_note-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-gambling_59-0"><a href="#cite_note-gambling-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> A 2008 case study reported successful use of naltrexone in suppressing and treating an internet pornography addiction.<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Interferon_alpha">Interferon alpha</h3></summary>
    
<p>Naltrexone is effective in suppressing the cytokine-mediated adverse neuropsychiatric effects of interferon alpha therapy.<span class="mw-ref" id="cite_ref-pmid16142050_62-0"><a href="#cite_note-pmid16142050-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-pmid17068950_63-0"><a href="#cite_note-pmid17068950-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Opioid antagonist § List of opioid antagonists</li>
<li><i>One Little Pill</i> (2014 film) - documentary about using naltrexone to treat alcohol use disorder</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2017-1"> <span id="mw-reference-text-cite_note-AHFS2017-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/naltrexone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/naltrexone.html'" tppabs="https://www.drugs.com/monograph/naltrexone.html" class="external text external">"Naltrexone Monograph for Professionals - Drugs.com"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20171109134845/https://www.drugs.com/monograph/naltrexone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20171109134845/https://www.drugs.com/monograph/naltrexone.html'" tppabs="https://web.archive.org/web/20171109134845/https://www.drugs.com/monograph/naltrexone.html" class="external text external">Archived</a> from the original on 9 November 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">9 November</span> 2017</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite id="CITEREFTranGriffinStoneVest2017" class="citation journal cs1">Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ (July 2017). "Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women". <i>Pharmacotherapy</i>. <b>37</b> (7): 824–839. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fphar.1958  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fphar.1958'" tppabs="https://doi.org/10.1002%2Fphar.1958" class="external text external">10.1002/phar.1958</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28543191  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28543191'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28543191" class="external text external">28543191</a>.</cite></span></li><li id="cite_note-Sad2012-3"> <span id="mw-reference-text-cite_note-Sad2012-3" class="mw-reference-text"><cite id="CITEREFSadockSadockSussman2012" class="citation book cs1">Sadock BJ, Sadock VA, Sussman N (2012). <a href="javascript:if(confirm('https://books.google.ca/books?id=qp-H3UruKvIC&pg=PT265  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=qp-H3UruKvIC&pg=PT265'" tppabs="https://books.google.ca/books?id=qp-H3UruKvIC&pg=PT265" class="external text external"><i>Kaplan &amp; Sadock's Pocket Handbook of Psychiatric Drug Treatment</i></a>. Lippincott Williams &amp; Wilkins. p.<span>&nbsp;</span>265. ISBN<span>&nbsp;</span><bdi>9781451154467</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20171205042100/https://books.google.ca/books?id=qp-H3UruKvIC&pg=PT265  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20171205042100/https://books.google.ca/books?id=qp-H3UruKvIC&pg=PT265'" tppabs="https://web.archive.org/web/20171205042100/https://books.google.ca/books?id=qp-H3UruKvIC&pg=PT265" class="external text external">Archived</a> from the original on 2017-12-05.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite class="citation journal cs1">"Naltrexone/bupropion for obesity". <i>Drug and Therapeutics Bulletin</i>. <b>55</b> (11): 126–129. November 2017. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fdtb.2017.11.0550  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fdtb.2017.11.0550'" tppabs="https://doi.org/10.1136%2Fdtb.2017.11.0550" class="external text external">10.1136/dtb.2017.11.0550</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29117992  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29117992'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29117992" class="external text external">29117992</a>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFAboujaoudeSalame2016" class="citation journal cs1">Aboujaoude E, Salame WO (August 2016). "Naltrexone: A Pan-Addiction Treatment?". <i>CNS Drugs</i>. <b>30</b> (8): 719–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40263-016-0373-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40263-016-0373-0'" tppabs="https://doi.org/10.1007%2Fs40263-016-0373-0" class="external text external">10.1007/s40263-016-0373-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27401883  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27401883'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27401883" class="external text external">27401883</a>.</cite></span></li><li id="cite_note-Ros2010-6"> <span id="mw-reference-text-cite_note-Ros2010-6" class="mw-reference-text"><cite id="CITEREFRösnerHackl-HerrwerthLeuchtVecchi2010" class="citation journal cs1">Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (December 2010). "Opioid antagonists for alcohol dependence". <i>The Cochrane Database of Systematic Reviews</i> (12): CD001867. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD001867.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD001867.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD001867.pub2" class="external text external">10.1002/14651858.CD001867.pub2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21154349  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21154349'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21154349" class="external text external">21154349</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFDonoghueElzerbiSaundersWhittington2015" class="citation journal cs1">Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C (June 2015). <a href="javascript:if(confirm('http://findings.org.uk/PHP/dl.php?file=Donoghue_K_1.txt&s=eb  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://findings.org.uk/PHP/dl.php?file=Donoghue_K_1.txt&s=eb'" tppabs="http://findings.org.uk/PHP/dl.php?file=Donoghue_K_1.txt&s=eb" class="external text external">"The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis"</a>. <i>Addiction</i>. <b>110</b> (6): 920–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fadd.12875  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fadd.12875'" tppabs="https://doi.org/10.1111%2Fadd.12875" class="external text external">10.1111/add.12875</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25664494  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25664494'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25664494" class="external text external">25664494</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFGarbutt2010" class="citation journal cs1">Garbutt JC (2010). "Efficacy and tolerability of naltrexone in the management of alcohol dependence". <i>Current Pharmaceutical Design</i>. <b>16</b> (19): 2091–7. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F138161210791516459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F138161210791516459'" tppabs="https://doi.org/10.2174%2F138161210791516459" class="external text external">10.2174/138161210791516459</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20482515  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20482515'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20482515" class="external text external">20482515</a>.</cite></span></li><li id="cite_note-Mai2013-9"> <span id="mw-reference-text-cite_note-Mai2013-9" class="mw-reference-text"><cite id="CITEREFMaiselBlodgettWilbourneHumphreys2013" class="citation journal cs1">Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (February 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823" class="external text external">"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?"</a>. <i>Addiction</i>. <b>108</b> (2): 275–93. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1360-0443.2012.04054.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1360-0443.2012.04054.x'" tppabs="https://doi.org/10.1111%2Fj.1360-0443.2012.04054.x" class="external text external">10.1111/j.1360-0443.2012.04054.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970823" class="external text external">3970823</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23075288  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23075288'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23075288" class="external text external">23075288</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFAnderson2013" class="citation web cs1">Anderson, Kenneth (Jul 28, 2013). <a href="javascript:if(confirm('https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone'" tppabs="https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone" class="external text external">"Drink Your Way Sober with Naltrexone"</a>. <i>Psychology Today</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20160917232955/https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160917232955/https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone'" tppabs="https://web.archive.org/web/20160917232955/https://www.psychologytoday.com/blog/overcoming-addiction/201307/drink-your-way-sober-naltrexone" class="external text external">Archived</a> from the original on 17 September 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">18 July</span> 2016</span>.</cite></span></li><li id="cite_note-Sin2001-11"> <span id="mw-reference-text-cite_note-Sin2001-11" class="mw-reference-text"><cite id="CITEREFSinclair2001" class="citation journal cs1">Sinclair JD (2001). <a href="javascript:if(confirm('https://doi.org/10.1093/alcalc/36.1.2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/alcalc/36.1.2'" tppabs="https://doi.org/10.1093/alcalc/36.1.2" class="external text external">"Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism"</a>. <i>Alcohol and Alcoholism</i>. <b>36</b> (1): 2–10. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Falcalc%2F36.1.2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Falcalc%2F36.1.2'" tppabs="https://doi.org/10.1093%2Falcalc%2F36.1.2" class="external text external">10.1093/alcalc/36.1.2</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11139409  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11139409'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11139409" class="external text external">11139409</a>.</cite></span></li><li id="cite_note-Shar2017-12"> <span id="mw-reference-text-cite_note-Shar2017-12" class="mw-reference-text"><cite id="CITEREFSharmaKellyMitchellGryczynski2017" class="citation journal cs1">Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O'Grady KE, Schwartz RP (June 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075636'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075636" class="external text external">"Update on Barriers to Pharmacotherapy for Opioid Use Disorders"</a>. <i>Current Psychiatry Reports</i>. <b>19</b> (6): 35. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11920-017-0783-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11920-017-0783-9'" tppabs="https://doi.org/10.1007%2Fs11920-017-0783-9" class="external text external">10.1007/s11920-017-0783-9</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075636'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075636" class="external text external">7075636</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28526967  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28526967'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28526967" class="external text external">28526967</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFSharmaBrunerBarnettFishman2016" class="citation journal cs1">Sharma B, Bruner A, Barnett G, Fishman M (July 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977" class="external text external">"Opioid Use Disorders"</a>. <i>Child and Adolescent Psychiatric Clinics of North America</i>. <b>25</b> (3): 473–87. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.chc.2016.03.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.chc.2016.03.002'" tppabs="https://doi.org/10.1016%2Fj.chc.2016.03.002" class="external text external">10.1016/j.chc.2016.03.002</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920977" class="external text external">4920977</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27338968  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27338968'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27338968" class="external text external">27338968</a>.</cite></span></li><li id="cite_note-ComerSullivan2006-14"> <span id="mw-reference-text-cite_note-ComerSullivan2006-14" class="mw-reference-text"><cite id="CITEREFComerSullivanYuRothenberg2006" class="citation journal cs1">Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP (February 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530" class="external text external">"Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial"</a>. <i>Archives of General Psychiatry</i>. <b>63</b> (2): 210–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Farchpsyc.63.2.210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchpsyc.63.2.210'" tppabs="https://doi.org/10.1001%2Farchpsyc.63.2.210" class="external text external">10.1001/archpsyc.63.2.210</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200530" class="external text external">4200530</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16461865  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16461865'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16461865" class="external text external">16461865</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFMinozziAmatoVecchiDavoli2011" class="citation journal cs1">Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A (April 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045778  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045778'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045778" class="external text external">"Oral naltrexone maintenance treatment for opioid dependence"</a>. <i>The Cochrane Database of Systematic Reviews</i> (4): CD001333. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD001333.pub4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD001333.pub4'" tppabs="https://doi.org/10.1002%2F14651858.CD001333.pub4" class="external text external">10.1002/14651858.CD001333.pub4</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045778  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045778'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045778" class="external text external">7045778</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21491383  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21491383'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21491383" class="external text external">21491383</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFJohanssonBerglundLindgren2006" class="citation journal cs1">Johansson BA, Berglund M, Lindgren A (April 2006). "Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review". <i>Addiction</i>. <b>101</b> (4): 491–503. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1360-0443.2006.01369.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1360-0443.2006.01369.x'" tppabs="https://doi.org/10.1111%2Fj.1360-0443.2006.01369.x" class="external text external">10.1111/j.1360-0443.2006.01369.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16548929  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16548929'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16548929" class="external text external">16548929</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFDavidLancasterSteadEvins2013" class="citation journal cs1">David SP, Lancaster T, Stead LF, Evins AE, Prochaska JJ (June 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652" class="external text external">"Opioid antagonists for smoking cessation"</a>. <i>The Cochrane Database of Systematic Reviews</i> (6): CD003086. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD003086.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD003086.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD003086.pub3" class="external text external">10.1002/14651858.CD003086.pub3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038652" class="external text external">4038652</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23744347  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23744347'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23744347" class="external text external">23744347</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFTrofimovitchBaumrucker2019" class="citation journal cs1">Trofimovitch, D; Baumrucker, SJ (October 2019). "Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes". <i>The American Journal of Hospice &amp; Palliative Care</i>. <b>36</b> (10): 907–912. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F1049909119838974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F1049909119838974'" tppabs="https://doi.org/10.1177%2F1049909119838974" class="external text external">10.1177/1049909119838974</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30917675  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30917675'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30917675" class="external text external">30917675</a>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFPattenSchultzBerlau2018" class="citation journal cs1">Patten, DK; Schultz, BG; Berlau, DJ (March 2018). "The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders". <i>Pharmacotherapy</i>. <b>38</b> (3): 382–389. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fphar.2086  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fphar.2086'" tppabs="https://doi.org/10.1002%2Fphar.2086" class="external text external">10.1002/phar.2086</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29377216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29377216'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29377216" class="external text external">29377216</a>.</cite></span></li><li id="cite_note-Milhorn2017-20"> <span id="mw-reference-text-cite_note-Milhorn2017-20" class="mw-reference-text"><cite id="CITEREFH._Thomas_Milhorn2017" class="citation book cs1">H. Thomas Milhorn (17 October 2017). <a href="javascript:if(confirm('https://books.google.com/books?id=wH86DwAAQBAJ&pg=PA88  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=wH86DwAAQBAJ&pg=PA88'" tppabs="https://books.google.com/books?id=wH86DwAAQBAJ&pg=PA88" class="external text external"><i>Substance Use Disorders: A Guide for the Primary Care Provider</i></a>. Springer International Publishing. pp.<span>&nbsp;</span>88–. ISBN<span>&nbsp;</span><bdi>978-3-319-63040-3</bdi>.</cite></span></li><li id="cite_note-MedicalNewsToday2006-21"> <span id="mw-reference-text-cite_note-MedicalNewsToday2006-21" class="mw-reference-text">"<a href="javascript:if(confirm('http://www.medicalnewstoday.com/articles/41707.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medicalnewstoday.com/articles/41707.php'" tppabs="http://www.medicalnewstoday.com/articles/41707.php" class="external text external">Alcoholism Once A Month Injectable Drug, Vivitrol, Approved By FDA</a> <a href="javascript:if(confirm('https://web.archive.org/web/20090105124047/http://www.medicalnewstoday.com/articles/41707.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090105124047/http://www.medicalnewstoday.com/articles/41707.php'" tppabs="https://web.archive.org/web/20090105124047/http://www.medicalnewstoday.com/articles/41707.php" class="external text external">Archived</a><span> 2009-01-05 at the </span>Wayback Machine," Medical News Today, April 16, 2006.</span></li><li id="cite_note-TGA-22"> <span id="mw-reference-text-cite_note-TGA-22" class="mw-reference-text"><cite id="CITEREFTherapeutic_Goods_Administration" class="citation web cs1">Therapeutic Goods Administration. <a href="javascript:if(confirm('https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView'" tppabs="https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView" class="external text external">"Australian Register of Therapeutic Goods Medicines"</a> <span class="cs1-format">(Online database of approved medicines)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20090514095145/https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090514095145/https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView'" tppabs="https://web.archive.org/web/20090514095145/https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines?OpenView" class="external text external">Archived</a> from the original on 2009-05-14<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-03-22</span></span>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite class="citation web cs1">Therapeutic Goods Administration. <a href="javascript:if(confirm('https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs%2FPublicHTML%2FpdfStore.nsf&docid=12AA89E8C8E53B46CA257FA7004211EE&agid=(PrintDetailsPublic)&actionid=1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs%2FPublicHTML%2FpdfStore.nsf&docid=12AA89E8C8E53B46CA257FA7004211EE&agid=(PrintDetailsPublic)&actionid=1'" tppabs="https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs%2FPublicHTML%2FpdfStore.nsf&docid=12AA89E8C8E53B46CA257FA7004211EE&agid=(PrintDetailsPublic)&actionid=1" class="external text external">"Australian Register of Therapeutic Goods Medicines"</a> <span class="cs1-format">(Online database of approved medicines, specific entry for "O'Neil Long Acting Naltrexone Implant")</span><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-04-27</span></span>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFHulseMorrisArnold-ReedTait2009" class="citation journal cs1">Hulse GK, Morris N, Arnold-Reed D, Tait RJ (October 2009). <a href="javascript:if(confirm('https://doi.org/10.1001/archgenpsychiatry.2009.130  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/archgenpsychiatry.2009.130'" tppabs="https://doi.org/10.1001/archgenpsychiatry.2009.130" class="external text external">"Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone"</a>. <i>Archives of General Psychiatry</i>. <b>66</b> (10): 1108–15. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Farchgenpsychiatry.2009.130  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchgenpsychiatry.2009.130'" tppabs="https://doi.org/10.1001%2Farchgenpsychiatry.2009.130" class="external text external">10.1001/archgenpsychiatry.2009.130</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19805701  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19805701'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19805701" class="external text external">19805701</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFPfohlAllenAtkinsonKnopman1986" class="citation journal cs1">Pfohl DN, Allen JI, Atkinson RL, Knopman DS, Malcolm RJ, Mitchell JE, Morley JE (1986). <a href="javascript:if(confirm('https://web.archive.org/web/20170121150620/https://archives.drugabuse.gov/pdf/monographs/download67.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170121150620/https://archives.drugabuse.gov/pdf/monographs/download67.html'" tppabs="https://web.archive.org/web/20170121150620/https://archives.drugabuse.gov/pdf/monographs/download67.html" class="external text external">"Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage"</a>. <i>NIDA Research Monograph</i>. <b>67</b>: 66–72. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3092099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3092099'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3092099" class="external text external">3092099</a>. Archived from <a href="javascript:if(confirm('https://archives.drugabuse.gov/pdf/monographs/download67.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archives.drugabuse.gov/pdf/monographs/download67.html'" tppabs="https://archives.drugabuse.gov/pdf/monographs/download67.html" class="external text external">the original</a> on 2017-01-21<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-01-23</span></span>.</cite></span></li><li id="cite_note-galanter-26"> <span id="mw-reference-text-cite_note-galanter-26" class="mw-reference-text">Galanter, Marc; Kleber, Herbert.  The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition. ISBN<span>&nbsp;</span>1585622761</span></li><li id="cite_note-pmid8114680-27"> <span id="mw-reference-text-cite_note-pmid8114680-27" class="mw-reference-text"><cite id="CITEREFRaynorKongChenYasuda1994" class="citation journal cs1">Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T (February 1994). <a href="javascript:if(confirm('http://molpharm.aspetjournals.org/content/45/2/330.short  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://molpharm.aspetjournals.org/content/45/2/330.short'" tppabs="http://molpharm.aspetjournals.org/content/45/2/330.short" class="external text external">"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors"</a>. <i>Molecular Pharmacology</i>. <b>45</b> (2): 330–4. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8114680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8114680'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8114680" class="external text external">8114680</a>.</cite></span></li><li id="cite_note-pmid7562497-28"> <span id="mw-reference-text-cite_note-pmid7562497-28" class="mw-reference-text"><cite id="CITEREFCoddShankSchupskyRaffa1995" class="citation journal cs1">Codd EE, Shank RP, Schupsky JJ, Raffa RB (September 1995). <a href="javascript:if(confirm('http://jpet.aspetjournals.org/content/274/3/1263.short  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jpet.aspetjournals.org/content/274/3/1263.short'" tppabs="http://jpet.aspetjournals.org/content/274/3/1263.short" class="external text external">"Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception"</a>. <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>274</b> (3): 1263–70. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7562497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7562497'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7562497" class="external text external">7562497</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFNiciuArias2013" class="citation journal cs1">Niciu MJ, Arias AJ (October 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601" class="external text external">"Targeted opioid receptor antagonists in the treatment of alcohol use disorders"</a>. <i>CNS Drugs</i>. <b>27</b> (10): 777–87. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40263-013-0096-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40263-013-0096-4'" tppabs="https://doi.org/10.1007%2Fs40263-013-0096-4" class="external text external">10.1007/s40263-013-0096-4</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600601" class="external text external">4600601</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23881605  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23881605'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23881605" class="external text external">23881605</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFWalkerKoob2008" class="citation journal cs1">Walker BM, Koob GF (February 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739278  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739278'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739278" class="external text external">"Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence"</a>. <i>Neuropsychopharmacology</i>. <b>33</b> (3): 643–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.npp.1301438  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.npp.1301438'" tppabs="https://doi.org/10.1038%2Fsj.npp.1301438" class="external text external">10.1038/sj.npp.1301438</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739278  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739278'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739278" class="external text external">2739278</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17473837  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17473837'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17473837" class="external text external">17473837</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFKoobVolkow2016" class="citation journal cs1">Koob GF, Volkow ND (August 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135092  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135092'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135092" class="external text external">"Neurobiology of addiction: a neurocircuitry analysis"</a>. <i>The Lancet. Psychiatry</i>. <b>3</b> (8): 760–73. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS2215-0366%2816%2900104-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS2215-0366%2816%2900104-8'" tppabs="https://doi.org/10.1016%2FS2215-0366%2816%2900104-8" class="external text external">10.1016/S2215-0366(16)00104-8</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135092  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135092'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135092" class="external text external">6135092</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27475769  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27475769'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27475769" class="external text external">27475769</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFKoobBuckCohenEdwards2014" class="citation journal cs1">Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, Schmeichel B, Vendruscolo LF, Wade CL, Whitfield TW, George O (January 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830720'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830720" class="external text external">"Addiction as a stress surfeit disorder"</a>. <i>Neuropharmacology</i>. 76 Pt B: 370–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neuropharm.2013.05.024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neuropharm.2013.05.024'" tppabs="https://doi.org/10.1016%2Fj.neuropharm.2013.05.024" class="external text external">10.1016/j.neuropharm.2013.05.024</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830720'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830720" class="external text external">3830720</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23747571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23747571'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23747571" class="external text external">23747571</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFRayBarrBlendyOslin2012" class="citation journal cs1">Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF (March 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007" class="external text external">"The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review"</a>. <i>Alcoholism, Clinical and Experimental Research</i>. <b>36</b> (3): 385–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1530-0277.2011.01633.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1530-0277.2011.01633.x'" tppabs="https://doi.org/10.1111%2Fj.1530-0277.2011.01633.x" class="external text external">10.1111/j.1530-0277.2011.01633.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249007" class="external text external">3249007</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21895723  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21895723'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21895723" class="external text external">21895723</a>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite id="CITEREFGarbuttGreenblattWestMorgan2014" class="citation journal cs1">Garbutt JC, Greenblatt AM, West SL, Morgan LC, Kampov-Polevoy A, Jordan HS, Bobashev GV (August 2014). "Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence". <i>Addiction</i>. <b>109</b> (8): 1274–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fadd.12557  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fadd.12557'" tppabs="https://doi.org/10.1111%2Fadd.12557" class="external text external">10.1111/add.12557</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24661324  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24661324'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24661324" class="external text external">24661324</a>.</cite></span></li><li id="cite_note-Dependence1974-35"> <span id="mw-reference-text-cite_note-Dependence1974-35" class="mw-reference-text"><cite id="CITEREFNational_Research_Council_(U.S.)._Committee_on_Problems_of_Drug_Dependence1974" class="citation book cs1">National Research Council (U.S.). Committee on Problems of Drug Dependence (1974). <a href="javascript:if(confirm('https://books.google.com/books?id=pEYrAAAAYAAJ&pg=PA265  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=pEYrAAAAYAAJ&pg=PA265'" tppabs="https://books.google.com/books?id=pEYrAAAAYAAJ&pg=PA265" class="external text external"><i>Report of the Thirty-sixth Annual Scientific Meeting: Committee on Problems of Drug Dependence, Mexico City, March 10-14, 1974</i></a>. National Academies. pp.<span>&nbsp;</span>265–. ISBN<span>&nbsp;</span><bdi>9780309022446</bdi>. NAP:13963.</cite></span></li><li id="cite_note-PadwaCunningham2010-36"> <span id="mw-reference-text-cite_note-PadwaCunningham2010-36" class="mw-reference-text"><cite id="CITEREFPadwaCunningham2010" class="citation book cs1">Padwa H, Cunningham J (2010). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/addictionreferen0000padw  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/addictionreferen0000padw'" tppabs="https://archive.org/details/addictionreferen0000padw" class="external text external"><i>Addiction: A Reference Encyclopedia</i></a></span>. ABC-CLIO. pp.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/addictionreferen0000padw/page/207  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/addictionreferen0000padw/page/207'" tppabs="https://archive.org/details/addictionreferen0000padw/page/207" class="external text external">207</a>–. ISBN<span>&nbsp;</span><bdi>978-1-59884-229-6</bdi>.</cite></span></li><li id="cite_note-Bennett2004-37"> <span id="mw-reference-text-cite_note-Bennett2004-37" class="mw-reference-text"><cite id="CITEREFG_Bennett2004" class="citation book cs1">G Bennett (14 January 2004). <a href="javascript:if(confirm('https://books.google.com/books?id=ft6IAgAAQBAJ&pg=PT112  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ft6IAgAAQBAJ&pg=PT112'" tppabs="https://books.google.com/books?id=ft6IAgAAQBAJ&pg=PT112" class="external text external"><i>Treating Drug Abusers</i></a>. Routledge. pp.<span>&nbsp;</span>112–. ISBN<span>&nbsp;</span><bdi>978-1-134-93173-6</bdi>.</cite></span></li><li id="cite_note-Wouk2009-38"> <span id="mw-reference-text-cite_note-Wouk2009-38" class="mw-reference-text"><cite id="CITEREFJoseph_Wouk2009" class="citation book cs1">Joseph Wouk (1 March 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=9hOBAgAAQBAJ&pg=RA1-PA78  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=9hOBAgAAQBAJ&pg=RA1-PA78'" tppabs="https://books.google.com/books?id=9hOBAgAAQBAJ&pg=RA1-PA78" class="external text external"><i>Google Ldn<span>&nbsp;</span>!</i></a>. Lulu.com. pp.<span>&nbsp;</span>78–88. ISBN<span>&nbsp;</span><bdi>978-0-578-00439-6</bdi>.</cite></span></li><li id="cite_note-Elks2014-39"> <span id="mw-reference-text-cite_note-Elks2014-39" class="mw-reference-text"><cite id="CITEREFJ._Elks2014" class="citation book cs1">J. Elks (14 November 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA851'" tppabs="https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA851" class="external text external"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. pp.<span>&nbsp;</span>851–. ISBN<span>&nbsp;</span><bdi>978-1-4757-2085-3</bdi>.</cite></span></li><li id="cite_note-IndexNominum2000-40"> <span id="mw-reference-text-cite_note-IndexNominum2000-40" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA715'" tppabs="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA715" class="external text external"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. 2000. pp.<span>&nbsp;</span>715–. ISBN<span>&nbsp;</span><bdi>978-3-88763-075-1</bdi>.</cite></span></li><li id="cite_note-MortonHall2012-41"> <span id="mw-reference-text-cite_note-MortonHall2012-41" class="mw-reference-text"><cite id="CITEREFMortonHall2012" class="citation book cs1">Morton IK, Hall JM (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189'" tppabs="https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189" class="external text external"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>189–. ISBN<span>&nbsp;</span><bdi>978-94-011-4439-1</bdi>.</cite></span></li><li id="cite_note-Drugs.com-42"> <span id="mw-reference-text-cite_note-Drugs.com-42" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/naltrexone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/naltrexone.html'" tppabs="https://www.drugs.com/international/naltrexone.html" class="external text external">"Naltrexone"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20171204114601/https://www.drugs.com/international/naltrexone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20171204114601/https://www.drugs.com/international/naltrexone.html'" tppabs="https://web.archive.org/web/20171204114601/https://www.drugs.com/international/naltrexone.html" class="external text external">Archived</a> from the original on 2017-12-04<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-12-04</span></span>.</cite></span></li><li id="cite_note-pmid18212797-43"> <span id="mw-reference-text-cite_note-pmid18212797-43" class="mw-reference-text"><cite id="CITEREFMcCann2008" class="citation journal cs1">McCann DJ (April 2008). "Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders". <i>Clinical Pharmacology and Therapeutics</i>. <b>83</b> (4): 627–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.clpt.6100503  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.clpt.6100503'" tppabs="https://doi.org/10.1038%2Fsj.clpt.6100503" class="external text external">10.1038/sj.clpt.6100503</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18212797  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18212797'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18212797" class="external text external">18212797</a>.</cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite id="CITEREFArmstrong2013" class="citation web cs1">Armstrong, Walter (7 May 2013). <a href="javascript:if(confirm('https://psmag.com/social-justice/vivitrol-help-control-addictions-57261  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://psmag.com/social-justice/vivitrol-help-control-addictions-57261'" tppabs="https://psmag.com/social-justice/vivitrol-help-control-addictions-57261" class="external text external">"A Shot in the Dark: Can Vivitrol Help Us Control Our Addictions?"</a>. <i>Pacific Standard</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20170913135050/https://psmag.com/social-justice/vivitrol-help-control-addictions-57261  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170913135050/https://psmag.com/social-justice/vivitrol-help-control-addictions-57261'" tppabs="https://web.archive.org/web/20170913135050/https://psmag.com/social-justice/vivitrol-help-control-addictions-57261" class="external text external">Archived</a> from the original on 13 September 2017.</cite></span></li><li id="cite_note-Lancet_Krupitsky_2011_naltrexone-45"> <span id="mw-reference-text-cite_note-Lancet_Krupitsky_2011_naltrexone-45" class="mw-reference-text"><cite id="CITEREFKrupitskyNunesLingIlleperuma2011" class="citation journal cs1">Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL (April 2011). "Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial". <i>Lancet</i>. <b>377</b> (9776): 1506–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0140-6736%2811%2960358-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0140-6736%2811%2960358-9'" tppabs="https://doi.org/10.1016%2Fs0140-6736%2811%2960358-9" class="external text external">10.1016/s0140-6736(11)60358-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21529928  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21529928'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21529928" class="external text external">21529928</a>.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite id="CITEREFWolfeCarrieriDasguptaBruce2011" class="citation journal cs1">Wolfe D, Carrieri MP, Dasgupta N, Bruce D, Wodak A (2011). "Injectable extended-release naltrexone for opioid dependence – Authors' reply". <i>The Lancet</i>. <b>378</b> (9792): 666. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2811%2961333-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2811%2961333-0'" tppabs="https://doi.org/10.1016%2FS0140-6736%2811%2961333-0" class="external text external">10.1016/S0140-6736(11)61333-0</a>.</cite></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite id="CITEREFTanumSolliLatifBenth2017" class="citation journal cs1">Tanum L, Solli KK, Latif ZE, Benth JŠ, Opheim A, Sharma-Haase K, Krajci P, Kunøe N (December 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583381  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583381'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583381" class="external text external">"Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial"</a>. <i>JAMA Psychiatry</i>. <b>74</b> (12): 1197–1205. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjamapsychiatry.2017.3206  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjamapsychiatry.2017.3206'" tppabs="https://doi.org/10.1001%2Fjamapsychiatry.2017.3206" class="external text external">10.1001/jamapsychiatry.2017.3206</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583381  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583381'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583381" class="external text external">6583381</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29049469  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29049469'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29049469" class="external text external">29049469</a>.</cite></span></li><li id="cite_note-NYT_2017_Vivitrol-48"> <span id="mw-reference-text-cite_note-NYT_2017_Vivitrol-48" class="mw-reference-text"><cite id="CITEREFGoodnoughZernike2017" class="citation news cs1">Goodnough A, Zernike K (June 11, 2017). <a href="javascript:if(confirm('https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html'" tppabs="https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html" class="external text external">"Seizing on Opioid Crisis, a Drug Maker Lobbies Hard for Its Product"</a>. <i>The New York Times</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20170611133547/https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170611133547/https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html'" tppabs="https://web.archive.org/web/20170611133547/https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html" class="external text external">Archived</a> from the original on June 11, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">June 11,</span> 2017</span>. <q>Advertising for Vivitrol on a subway car in Brooklyn last month. Marketing for the drug has shifted into high gear.</q></cite></span></li><li id="cite_note-Tom-Price-Letter-Re-MAT_2017-49"> <span id="mw-reference-text-cite_note-Tom-Price-Letter-Re-MAT_2017-49" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html'" tppabs="https://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html" class="external text external">"Letter to Tom Price"</a>. May 2017. <a href="javascript:if(confirm('https://web.archive.org/web/20170625103407/http://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170625103407/http://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html'" tppabs="https://web.archive.org/web/20170625103407/http://www.documentcloud.org/documents/3723472-Tom-Price-Letter-Re-MAT.html" class="external text external">Archived</a> from the original on June 25, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">June 11,</span> 2017</span>.</cite></span></li><li id="cite_note-SimeonAbugel2008-50"> <span id="mw-reference-text-cite_note-SimeonAbugel2008-50" class="mw-reference-text"><cite id="CITEREFSimeonAbugel2008" class="citation book cs1">Simeon D, Abugel J (10 October 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=ONLyq-mVLuIC&pg=PA166  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ONLyq-mVLuIC&pg=PA166'" tppabs="https://books.google.com/books?id=ONLyq-mVLuIC&pg=PA166" class="external text external"><i>Feeling Unreal: Depersonalization Disorder and the Loss of the Self</i></a>. Oxford University Press. pp.<span>&nbsp;</span>166–. ISBN<span>&nbsp;</span><bdi>978-0-19-976635-2</bdi>.</cite></span></li><li id="cite_note-PhDPhD2014-51"> <span id="mw-reference-text-cite_note-PhDPhD2014-51" class="mw-reference-text"><cite id="CITEREFLaniusPaulsenCorrigan2014" class="citation book cs1">Lanius UF, Paulsen SL, Corrigan FM (13 May 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0i-FAwAAQBAJ&pg=PA489  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0i-FAwAAQBAJ&pg=PA489'" tppabs="https://books.google.com/books?id=0i-FAwAAQBAJ&pg=PA489" class="external text external"><i>Neurobiology and Treatment of Traumatic Dissociation: Towards an Embodied Self</i></a>. Springer Publishing Company. pp.<span>&nbsp;</span>489–. ISBN<span>&nbsp;</span><bdi>978-0-8261-0632-2</bdi>.</cite></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite id="CITEREFSierra2008" class="citation journal cs1">Sierra M (January 2008). "Depersonalization disorder: pharmacological approaches". <i>Expert Review of Neurotherapeutics</i>. <b>8</b> (1): 19–26. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F14737175.8.1.19  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F14737175.8.1.19'" tppabs="https://doi.org/10.1586%2F14737175.8.1.19" class="external text external">10.1586/14737175.8.1.19</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18088198  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18088198'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18088198" class="external text external">18088198</a>.</cite></span></li><li id="cite_note-Novella-53"> <span id="mw-reference-text-cite_note-Novella-53" class="mw-reference-text"><cite id="CITEREFNovella2010" class="citation web cs1">Novella, Steven (5 May 2010). <a href="javascript:if(confirm('http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/'" tppabs="http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/" class="external text external">"Low Dose Naltrexone – Bogus or Cutting Edge Science?"</a>. <i>Science-Based Medicine</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20110708043917/http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110708043917/http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/'" tppabs="https://web.archive.org/web/20110708043917/http://www.sciencebasedmedicine.org/index.php/low-dose-naltrexone-bogus-or-cutting-edge-science/" class="external text external">Archived</a> from the original on 8 July 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2011</span>.</cite></span></li><li id="cite_note-ldntxfm-54"> <span id="mw-reference-text-cite_note-ldntxfm-54" class="mw-reference-text"><cite id="CITEREFYoungerMackey2009" class="citation journal cs1">Younger J, Mackey S (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387" class="external text external">"Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study"</a>. <i>Pain Medicine</i>. <b>10</b> (4): 663–72. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4637.2009.00613.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4637.2009.00613.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4637.2009.00613.x" class="external text external">10.1111/j.1526-4637.2009.00613.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387" class="external text external">2891387</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19453963  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19453963'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19453963" class="external text external">19453963</a>.</cite></span></li><li id="cite_note-NMSS-55"> <span id="mw-reference-text-cite_note-NMSS-55" class="mw-reference-text"><cite id="CITEREFBowling" class="citation web cs1">Bowling, Allen C. <a href="javascript:if(confirm('https://web.archive.org/web/20111222063116/http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20111222063116/http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx'" tppabs="https://web.archive.org/web/20111222063116/http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx" class="external text external">"Low-dose naltrexone (LDN) The "411" on LDN"</a>. National Multiple Sclerosis Society. Archived from <a href="javascript:if(confirm('http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx'" tppabs="http://www.nationalmssociety.org/multimedia-library/momentum-magazine/back-issues/momentum-spring-09/index.aspx" class="external text external">the original</a> on 22 December 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">6 July</span> 2011</span>.</cite></span></li><li id="cite_note-56"> <span id="mw-reference-text-cite_note-56" class="mw-reference-text"><cite id="CITEREFSmithGuptaSmith1995" class="citation journal cs1">Smith SG, Gupta KK, Smith SH (1995). "Effects of naltrexone on self-injury, stereotypy, and social behavior of adults with developmental disabilities". <i>Journal of Developmental and Physical Disabilities</i>. <b>7</b> (2): 137–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2FBF02684958  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2FBF02684958'" tppabs="https://doi.org/10.1007%2FBF02684958" class="external text external">10.1007/BF02684958</a>.</cite></span></li><li id="cite_note-57"> <span id="mw-reference-text-cite_note-57" class="mw-reference-text"><cite id="CITEREFManley1998" class="citation news cs1">Manley C (1998-03-20). <a href="javascript:if(confirm('http://www.mc.vanderbilt.edu/reporter/index.html?ID=461  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.mc.vanderbilt.edu/reporter/index.html?ID=461'" tppabs="http://www.mc.vanderbilt.edu/reporter/index.html?ID=461" class="external text external">"Self-injuries may have biochemical base: study"</a>. The Reporter. <a href="javascript:if(confirm('https://web.archive.org/web/20090105011250/http://www.mc.vanderbilt.edu/reporter/index.html?ID=461  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090105011250/http://www.mc.vanderbilt.edu/reporter/index.html?ID=461'" tppabs="https://web.archive.org/web/20090105011250/http://www.mc.vanderbilt.edu/reporter/index.html?ID=461" class="external text external">Archived</a> from the original on 2009-01-05.</cite></span></li><li id="cite_note-58"> <span id="mw-reference-text-cite_note-58" class="mw-reference-text"><cite id="CITEREFGrantKimOdlaug2009" class="citation journal cs1">Grant JE, Kim SW, Odlaug BL (April 2009). "A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania". <i>Biological Psychiatry</i>. <b>65</b> (7): 600–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.biopsych.2008.11.022  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.biopsych.2008.11.022'" tppabs="https://doi.org/10.1016%2Fj.biopsych.2008.11.022" class="external text external">10.1016/j.biopsych.2008.11.022</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19217077  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19217077'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19217077" class="external text external">19217077</a>. <a href="javascript:if(confirm('https://www.sciencedaily.com/releases/2009/04/090401101900.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sciencedaily.com/releases/2009/04/090401101900.htm'" tppabs="https://www.sciencedaily.com/releases/2009/04/090401101900.htm" class="external text external">Lay summary</a> <span>–</span> <i>Science Daily</i> (April 3, 2009).</cite></span></li><li id="cite_note-gambling-59"> <span id="mw-reference-text-cite_note-gambling-59" class="mw-reference-text"><span>Clinical trial number </span><i><a href="javascript:if(confirm('https://www.clinicaltrials.gov/show/NCT00326807  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.clinicaltrials.gov/show/NCT00326807'" tppabs="https://www.clinicaltrials.gov/show/NCT00326807" class="external text external">NCT00326807</a></i><span> for "A Randomized, Double-Blind, Placebo-Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling" at </span>ClinicalTrials.gov</span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite id="CITEREFKimGrantAdsonShin2001" class="citation journal cs1">Kim SW, Grant JE, Adson DE, Shin YC (June 2001). "Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling". <i>Biological Psychiatry</i>. <b>49</b> (11): 914–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0006-3223%2801%2901079-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0006-3223%2801%2901079-4'" tppabs="https://doi.org/10.1016%2FS0006-3223%2801%2901079-4" class="external text external">10.1016/S0006-3223(01)01079-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11377409  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11377409'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11377409" class="external text external">11377409</a>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFBostwickBucci2008" class="citation journal cs1">Bostwick JM, Bucci JA (February 2008). <a href="javascript:if(confirm('https://doi.org/10.4065/83.2.226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065/83.2.226'" tppabs="https://doi.org/10.4065/83.2.226" class="external text external">"Internet sex addiction treated with naltrexone"</a>. <i>Mayo Clinic Proceedings</i>. <b>83</b> (2): 226–30. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4065%2F83.2.226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065%2F83.2.226'" tppabs="https://doi.org/10.4065%2F83.2.226" class="external text external">10.4065/83.2.226</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18241634  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18241634'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18241634" class="external text external">18241634</a>.</cite></span></li><li id="cite_note-pmid16142050-62"> <span id="mw-reference-text-cite_note-pmid16142050-62" class="mw-reference-text"><cite id="CITEREFVignauKarilaCostisellaCanva2005" class="citation journal cs1">Vignau J, Karila L, Costisella O, Canva V (2005). "[Hepatitis C, interferon a and depression: main physiopathologic hypothesis]" <span>[</span>Hepatitis C, interferon a and depression: main physiopathologic hypothesis<span>]</span>. <i>L'Encephale</i> (in French). <b>31</b> (3): 349–57. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0013-7006%2805%2982400-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0013-7006%2805%2982400-5'" tppabs="https://doi.org/10.1016%2Fs0013-7006%2805%2982400-5" class="external text external">10.1016/s0013-7006(05)82400-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16142050  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16142050'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16142050" class="external text external">16142050</a>. INIST:<a href="javascript:if(confirm('https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16920336  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16920336'" tppabs="https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16920336" class="external text external">16920336</a>.</cite></span></li><li id="cite_note-pmid17068950-63"> <span id="mw-reference-text-cite_note-pmid17068950-63" class="mw-reference-text"><cite id="CITEREFMałyszczakInglotPawłowskiCzarnecki2006" class="citation journal cs1">Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Kiejna A (2006). <a href="javascript:if(confirm('http://www.psychiatriapsychoterapia.pl/?a=articles_show&id=459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.psychiatriapsychoterapia.pl/?a=articles_show&id=459'" tppabs="http://www.psychiatriapsychoterapia.pl/?a=articles_show&id=459" class="external text external">"<span>[</span>Neuropsychiatric symptoms related to interferon alpha<span>]</span>"</a> <span>[</span>Neuropsychiatric symptoms related to interferon alpha<span>]</span>. <i>Psychiatria Polska</i> (in Polish). <b>40</b> (4): 787–97. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17068950  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17068950'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17068950" class="external text external">17068950</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20170202010519/http://www.psychiatriapsychoterapia.pl/?a=articles_show&id=459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170202010519/http://www.psychiatriapsychoterapia.pl/?a=articles_show&id=459'" tppabs="https://web.archive.org/web/20170202010519/http://www.psychiatriapsychoterapia.pl/?a=articles_show&id=459" class="external text external">Archived</a> from the original on 2017-02-02.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/naltrexone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/naltrexone'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/naltrexone" class="external text external">"Naltrexone"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Treatment_of_drug_dependence_(N07B)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Treatment_of_drug_dependence_(N07B)" style="font-size:114%;margin:0 4em">Treatment of drug dependence (N07B)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Nicotine dependence</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Cytisine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytisine" title="Cytisine">Cytisine</a></li>
<li>Lobeline</li>
<li><a href="Mecamylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mecamylamine" title="Mecamylamine">Mecamylamine</a></li>
<li><a href="Varenicline.htm" tppabs="https://ptable.com/wiki/compounds/A/Varenicline" title="Varenicline">Varenicline</a></li>
<li><i><abbr>AA</abbr></i> (<a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">Clonidine</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alcohol dependence</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><abbr>AD</abbr> inhibitor</i> (<a href="Disulfiram.htm" tppabs="https://ptable.com/wiki/compounds/A/Disulfiram" title="Disulfiram">Disulfiram</a></li>
<li>Calcium carbimide</li>
<li>Hydrogen cyanamide)</li>
<li><a href="Acamprosate.htm" tppabs="https://ptable.com/wiki/compounds/A/Acamprosate" title="Acamprosate">Acamprosate</a></li>
<li><i>Opioid antagonists</i>
<ul><li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a>)</li>
<li>κ-Opioid receptor antagonists
<ul><li>Aticaprant</li></ul></li></ul></li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><i><abbr>AA</abbr></i> (<a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">Clonidine</a>)</li>
<li><a href="Baclofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Baclofen" title="Baclofen">Baclofen</a></li>
<li>Metadoxine</li>
<li>Phenibut</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Opioid dependence</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><abbr>AA</abbr></i> (<a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">Clonidine</a></li>
<li><a href="Lofexidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lofexidine" title="Lofexidine">Lofexidine</a>)</li>
<li>Ibogaine</li>
<li><i>Opioids</i>
<ul><li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a> (+naloxone)</li>
<li><a href="Levacetylmethadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levacetylmethadol" title="Levacetylmethadol">Levacetylmethadol</a></li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li><a href="Dihydrocodeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrocodeine" title="Dihydrocodeine">Dihydrocodeine</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone (extended-release)</a></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine (extended-release)</a></li></ul></li>
<li><i>Opioid antagonists</i> (<a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Benzodiazepine dependence</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><abbr>AA</abbr></i> (<a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">Clonidine</a>)</li>
<li><i>Benzodiazepines</i> (<a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">Diazepam</a></li>
<li><a href="Lorazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Lorazepam" title="Lorazepam">Lorazepam</a></li>
<li><a href="Chlordiazepoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlordiazepoxide" title="Chlordiazepoxide">Chlordiazepoxide</a></li>
<li><a href="Oxazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxazepam" title="Oxazepam">Oxazepam</a>)</li>
<li><i><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a></i> (<a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Research</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"><i><a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">Salvia divinorum</a></i></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Opioid_receptor_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Opioid_receptor_modulators" style="font-size:114%;margin:0 4em">Opioid receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>MOR</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists (abridged; see here for a full list):</i> 3-HO-PCP</li>
<li><span class="new">7-Acetoxymitragynine</span></li>
<li>7-Hydroxymitragynine</li>
<li><span class="new">ψ-Akuammigine</span></li>
<li>α-Chlornaltrexamine</li>
<li><span class="new">α-Narcotine</span></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine'" tppabs="https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine" title="Acetyldihydrocodeine">Acetyldihydrocodeine</a></li>
<li>Acetylfentanyl</li>
<li>Acrylfentanyl</li>
<li>Adrenorphin (metorphamide)</li>
<li>AH-7921</li>
<li>Akuammicine</li>
<li><span class="new">Akuammidine</span></li>
<li><a href="Alfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfentanil" title="Alfentanil">Alfentanil</a></li>
<li><a href="Anileridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anileridine" title="Anileridine">Anileridine</a></li>
<li>Apparicine</li>
<li>β-Endorphin</li>
<li><span class="new">BAM-12P</span></li>
<li><span class="new">BAM-18P</span></li>
<li><span class="new">BAM-22P</span></li>
<li>Benzhydrocodone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Benzylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Benzylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Benzylmorphine" title="Benzylmorphine">Benzylmorphine</a></li>
<li><a href="Bezitramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezitramide" title="Bezitramide">Bezitramide</a></li>
<li>Biphalin</li>
<li><span class="new">BU08070</span></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>Butyrfentanyl</li>
<li>BW373U86</li>
<li><a href="Carfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Carfentanil" title="Carfentanil">Carfentanil</a></li>
<li>Casokefamide</li>
<li>Cebranopadol</li>
<li>Chloroxymorphamine</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li>DADLE</li>
<li>DAMGO (DAGO)</li>
<li>Dermorphin</li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a></li>
<li><a href="Dextromoramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromoramide" title="Dextromoramide">Dextromoramide</a></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene (propoxyphene)</a></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Dimenoxadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenoxadol" title="Dimenoxadol">Dimenoxadol</a></li>
<li>Dimethylaminopivalophenone</li>
<li>Eluxadoline</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydrocodeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrocodeine" title="Dihydrocodeine">Dihydrocodeine</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>Dinalbuphine sebacate</li>
<li><a href="Diphenoxylate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenoxylate" title="Diphenoxylate">Diphenoxylate</a></li>
<li><a href="Dipipanone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipipanone" title="Dipipanone">Dipipanone</a></li>
<li>Dynorphin A</li>
<li><a href="Embutramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Embutramide" title="Embutramide">Embutramide</a></li>
<li>Endomorphin-1</li>
<li>Endomorphin-2</li>
<li>Eseroline</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Ethylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Ethylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Ethylmorphine" title="Ethylmorphine">Ethylmorphine</a></li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li>Fluorophen</li>
<li>Frakefamide</li>
<li>Furanylfentanyl</li>
<li>Hemorphin-4</li>
<li>Herkinorin</li>
<li>Hodgkinsine</li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphinol" title="Hydromorphinol">Hydromorphinol</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>IBNtxA</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Ketobemidone</li>
<li>Kratom</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Lefetamine</li>
<li>Leu-enkephalin</li>
<li><a href="Levacetylmethadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levacetylmethadol" title="Levacetylmethadol">Levacetylmethadol</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li><a href="Loperamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Loperamide" title="Loperamide">Loperamide</a></li>
<li><span class="new">Loxicodegol</span></li>
<li>Matrine</li>
<li>Meptazinol</li>
<li>Met-enkephalin (metenkefalin)</li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li>Metkefamide</li>
<li>Metopon</li>
<li>Mitragynine</li>
<li>Mitragynine pseudoindoxyl</li>
<li>Morphiceptin</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><span class="new">NalBzOH</span></li>
<li>Nalmexone</li>
<li>Naltalimide</li>
<li><span class="new">Neopine</span></li>
<li>NFEPP</li>
<li>Nicocodeine</li>
<li>Nicodicodine</li>
<li>Nicomorphine</li>
<li><span class="new">NKTR-181</span></li>
<li>Norketamine</li>
<li><a href="Octreotide.htm" tppabs="https://ptable.com/wiki/compounds/A/Octreotide" title="Octreotide">Octreotide</a></li>
<li>Oliceridine</li>
<li>OM-3-MNZ</li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li>Oxymorphazone</li>
<li><span class="new">Oxymorphonazine</span></li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li><span class="new">Oxymorphone phenylhydrazone</span></li>
<li><span class="new">OxyPNPH</span></li>
<li><i>Papaver somniferum</i> (opium)</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li>Pericine</li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenazocine</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Piminodine</li>
<li>Piritramide</li>
<li><span class="new">PL-017</span></li>
<li><a href="Prodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prodine" title="Prodine">Prodine</a></li>
<li>Propiram</li>
<li>PZM21</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li><a href="Remifentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Remifentanil" title="Remifentanil">Remifentanil</a></li>
<li><span class="new">Salsolinol</span></li>
<li>SC-17599</li>
<li><a href="Sinomenine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sinomenine" title="Sinomenine">Sinomenine</a></li>
<li><a href="Sufentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Sufentanil" title="Sufentanil">Sufentanil</a></li>
<li>Tapentadol</li>
<li>Tetrahydropapaveroline</li>
<li><span class="new">TH-030418</span></li>
<li><a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">Thebaine</a></li>
<li>Thienorphine</li>
<li>Tianeptine</li>
<li>Tilidine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li>Trimebutine</li>
<li>TRIMU 5</li>
<li><span class="new">TRV734</span></li>
<li><span class="new">Tubotaiwine</span></li>
<li>U-47700</li>
<li>Valorphin</li>
<li>Viminol</li>
<li>Xorphanol</li></ul>

<ul><li><i>PAMs:</i> <span class="new">BMS-986121</span></li>
<li><span class="new">BMS-986122</span></li></ul>

<ul><li><i>Antagonists:</i> (3S,4S)-Picenadol</li>
<li>2-(S)-N,N-(R)-Viminol</li>
<li><span class="new">3CS-nalmefene</span></li>
<li>4-Caffeoyl-1,5-quinide</li>
<li><span class="new">4′-Hydroxyflavanone</span></li>
<li>4',7-Dihydroxyflavone</li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li>18-MC</li>
<li><span class="new">α-Gliadin</span></li>
<li>β-Chlornaltrexamine</li>
<li>β-Funaltrexamine</li>
<li>Akuammine</li>
<li><a href="Alvimopan.htm" tppabs="https://ptable.com/wiki/compounds/A/Alvimopan" title="Alvimopan">Alvimopan</a></li>
<li>AM-251</li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li>AT-076</li>
<li>Axelopran</li>
<li>Bevenopran</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>Clocinnamox</li>
<li>CTAP</li>
<li><span class="new">CTOP</span></li>
<li><span class="new">Cyclofoxy</span></li>
<li>Cyprodime</li>
<li>Diacetylnalorphine</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>ECG</li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li>Eptazocine</li>
<li>Gemazocine</li>
<li><span class="new">Ginsenoside R</span></li>
<li>Hyperoside</li>
<li>Ibogaine</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Lobeline</li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li><span class="new">Methocinnamox</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">Methylsamidorphan chloride</span></li>
<li>Naldemedine</li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li>Nalodeine (N-allylnorcodeine)</li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Nalorphine dinicotinate</li>
<li>Naloxazone</li>
<li>Naloxegol</li>
<li>Naloxol</li>
<li>Naloxonazine</li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><span class="new">Naltrexazone</span></li>
<li><span class="new">Naltrexonazine</span></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltrindole</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Noribogaine</li>
<li>Oxilorphan</li>
<li>Pawhuskin A</li>
<li><a href="Rimonabant.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimonabant" title="Rimonabant">Rimonabant</a></li>
<li>Quadazocine</li>
<li>Samidorphan</li>
<li>Taxifolin</li></ul>

<ul><li><i>Unknown/unsorted:</i> <a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li><span class="new">Dihydroakuuamine</span></li>
<li>Tabernanthine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>DOR</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">3CS-nalmefene</span></li>
<li>6'-GNTI</li>
<li>7-SIOM</li>
<li><span class="new">ADL-5747 (PF-04856881)</span></li>
<li><span class="new">ADL-5859</span></li>
<li>Alazocine (SKF-10047)</li>
<li><a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><span class="new">AR-M100390 (ARM390)</span></li>
<li><span class="new">AZD2327</span></li>
<li>β-Endorphin</li>
<li><span class="new">BAM-18P</span></li>
<li>Biphalin</li>
<li>BU-48</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>BW373U86</li>
<li>Casokefamide</li>
<li>Cebranopadol</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>DADLE</li>
<li>Deltorphin A</li>
<li>Deltorphin I</li>
<li><span class="new">Deltorphin II</span></li>
<li>Desmethylclozapine</li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>DPDPE</li>
<li>DPI-221</li>
<li>DPI-3290</li>
<li><span class="new">DSLET</span></li>
<li>Ethylketazocine</li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><span class="new">FIT</span></li>
<li>Fluorophen</li>
<li>Hemorphin-4</li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>Ibogaine</li>
<li>Isomethadone</li>
<li><span class="new">JNJ-20788560</span></li>
<li><span class="new">KNT-127</span></li>
<li>Kratom</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Leu-enkephalin</li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>Lofentanil</li>
<li>Met-enkephalin (metenkefalin)</li>
<li>Metazocine</li>
<li>Metkefamide</li>
<li>Mitragynine</li>
<li>Mitragynine pseudoindoxyl</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li>N-Phenethyl-14-ethoxymetopon</li>
<li>Norbuprenorphine</li>
<li><span class="new">NalBzOH</span></li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Proglumide</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>RWJ-394674</li>
<li>Samidorphan</li>
<li><span class="new">SB-235863</span></li>
<li>SNC-80</li>
<li><span class="new">SNC-162</span></li>
<li>TAN-67 (SB-205,607)</li>
<li><span class="new">TH-030418</span></li>
<li><a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">Thebaine</a></li>
<li>Thiobromadol (C-8813)</li>
<li>Tonazocine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li><span class="new">TRV250</span></li>
<li>Xorphanol</li>
<li>Zenazocine</li></ul>

<ul><li><i>Antagonists:</i> 4',7-Dihydroxyflavone</li>
<li><span class="new">5'-NTII</span></li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li><span class="new">α-Santolol</span></li>
<li>β-Chlornaltrexamine</li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li>AT-076</li>
<li>Axelopran</li>
<li>Bevenopran</li>
<li><span class="new">BNTX</span></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>Clocinnamox</li>
<li>Diacetylnalorphine</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>ECG</li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li>Eluxadoline</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li><span class="new">ICI-154129</span></li>
<li><span class="new">ICI-174864</span></li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">Methylnaltrindole</span></li>
<li><span class="new">N-Benzylnaltrindole</span></li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltriben</li>
<li>Naltrindole</li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Noribogaine</li>
<li>Pawhuskin A</li>
<li>Quadazocine</li>
<li><span class="new">SDM25N</span></li>
<li>SoRI-9409</li>
<li>Taxifolin</li>
<li>Thienorphine</li></ul>

<ul><li><i>Unknown/unsorted:</i> 18-MC</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li>Tabernanthine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>KOR</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">3CS-nalmefene</span></li>
<li>6'-GNTI</li>
<li>8-CAC</li>
<li>18-MC</li>
<li>14-Methoxymetopon</li>
<li>β-Chlornaltrexamine</li>
<li>β-Funaltrexamine</li>
<li>Adrenorphin (metorphamide)</li>
<li><span class="new">Akuuamicine</span></li>
<li>Alazocine (SKF-10047)</li>
<li><span class="new">Allomatrine</span></li>
<li><span class="new">Apadoline</span></li>
<li>Asimadoline</li>
<li><span class="new">BAM-12P</span></li>
<li><span class="new">BAM-18P</span></li>
<li><span class="new">BAM-22P</span></li>
<li>Big dynorphin</li>
<li>Bremazocine</li>
<li>BRL-52537</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>BW373U86</li>
<li>Cebranopadol</li>
<li>Ciprefadol</li>
<li>CR665</li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>Cyclorphan</li>
<li><a href="Cyprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyprenorphine" title="Cyprenorphine">Cyprenorphine</a></li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li>Diacetylnalorphine</li>
<li>Difelikefalin</li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>Dinalbuphine sebacate</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>Dynorphin A</li>
<li>Dynorphin B (rimorphin)</li>
<li>Eluxadoline</li>
<li>Enadoline</li>
<li>Eptazocine</li>
<li><span class="new">Erinacine E</span></li>
<li>Ethylketazocine</li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li>Fedotozine</li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li>Gemazocine</li>
<li>GR-89696</li>
<li><span class="new">GR-103545</span></li>
<li>Hemorphin-4</li>
<li>Herkinorin</li>
<li><span class="new">HS665</span></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>HZ-2</li>
<li>Ibogaine</li>
<li>ICI-199,441</li>
<li>ICI-204,448</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Ketazocine</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Leumorphin (dynorphin B-29)</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>Lofentanil</li>
<li>LPK-26</li>
<li>Lufuradom</li>
<li>Matrine</li>
<li><span class="new">MB-1C-OH</span></li>
<li><a href="Menthol.htm" tppabs="https://ptable.com/wiki/compounds/A/Menthol" title="Menthol">Menthol</a></li>
<li>Metazocine</li>
<li>Metkefamide</li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li>Moxazocine</li>
<li><span class="new">MR-2034</span></li>
<li><span class="new">N-MPPP</span></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><span class="new">NalBzOH</span></li>
<li>Nalfurafine</li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li>Nalodeine (N-allylnorcodeine)</li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Naltriben</li>
<li>Niravoline</li>
<li>Norbuprenorphine</li>
<li>Norbuprenorphine-3-glucuronide</li>
<li>Noribogaine</li>
<li>Norketamine</li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li>Oxilorphan</li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenazocine</li>
<li>Proxorphan</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>RB-64</li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a> (<a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">salvia</a>)</li>
<li>Salvinorin B ethoxymethyl ether</li>
<li>Salvinorin B methoxymethyl ether</li>
<li>Samidorphan</li>
<li>Spiradoline (U-62,066)</li>
<li><span class="new">TH-030418</span></li>
<li>Thienorphine</li>
<li>Tifluadom</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, desipramine, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>)</li>
<li>U-50488</li>
<li><span class="new">U-54,494A</span></li>
<li>U-69,593</li>
<li>Xorphanol</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">4′-Hydroxyflavanone</span></li>
<li>4',7-Dihydroxyflavone</li>
<li>5'-GNTI</li>
<li>6'-GNTI</li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li>β-Chlornaltrexamine</li>
<li>Buprenorphine/samidorphan</li>
<li><a href="Amentoflavone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amentoflavone" title="Amentoflavone">Amentoflavone</a></li>
<li><span class="new">ANTI</span></li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li><span class="new">Arodyne</span></li>
<li>AT-076</li>
<li>Aticaprant</li>
<li>Axelopran</li>
<li><span class="new">AZ-MTAB</span></li>
<li>Binaltorphimine</li>
<li>BU09059</li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>CERC-501 (LY-2456302)</li>
<li>Clocinnamox</li>
<li><span class="new">Cyclofoxy</span></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><span class="new">DIPPA</span></li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li>ECG</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li>Hyperoside</li>
<li>JDTic</li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li><span class="new">LY-2444296</span></li>
<li>LY-2459989</li>
<li><span class="new">LY-2795050</span></li>
<li><span class="new">MeJDTic</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">ML190</span></li>
<li><span class="new">ML350</span></li>
<li><span class="new">MR-2266</span></li>
<li><span class="new">N-Fluoropropyl-JDTic</span></li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltrindole</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Norbinaltorphimine</li>
<li>Noribogaine</li>
<li>Pawhuskin A</li>
<li>PF-4455242</li>
<li>RB-64</li>
<li>Quadazocine</li>
<li>Taxifolin</li>
<li><span class="new">UPHIT</span></li>
<li>Zyklophin</li></ul>

<ul><li><i>Unknown/unsorted:</i> Akuammicine</li>
<li>Akuammine</li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li><span class="new">Dihydroakuuamine</span></li>
<li>Ibogamine</li>
<li>Tabernanthine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>NOP</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">(Arg14,Lys15)Nociceptin</span></li>
<li><span class="new">((pF)Phe<sup>4</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li><span class="new">(Phe<sup>1</sup>Ψ(CH<sub>2</sub>-NH)Gly<sup>2</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li><span class="new">Ac-RYYRWK-NH<sub>2</sub></span></li>
<li><span class="new">Ac-RYYRIK-NH<sub>2</sub></span></li>
<li><span class="new">BU08070</span></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li>Cebranopadol</li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><span class="new">JNJ-19385899</span></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>MCOPPB</li>
<li><span class="new">MT-7716</span></li>
<li>NNC 63-0532</li>
<li>Nociceptin (orphanin FQ)</li>
<li><span class="new">Nociceptin (1-11)</span></li>
<li><span class="new">Nociceptin (1-13)NH<sub>2</sub></span></li>
<li>Norbuprenorphine</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>Ro64-6198</li>
<li><span class="new">Ro65-6570</span></li>
<li><span class="new">SCH-221510</span></li>
<li><span class="new">SCH-486757</span></li>
<li><span class="new">SR-8993</span></li>
<li><span class="new">SR-16435</span></li>
<li><span class="new">TH-030418</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">(Nphe<sup>1</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li>AT-076</li>
<li><span class="new">BAN-ORL-24</span></li>
<li>BTRX-246040 (LY-2940094)</li>
<li>J-113,397</li>
<li>JTC-801</li>
<li><span class="new">NalBzOH</span></li>
<li><span class="new">Nociceptin (1-7)</span></li>
<li><span class="new">Nocistatin</span></li>
<li>SB-612,111</li>
<li><span class="new">SR-16430</span></li>
<li>Thienorphine</li>
<li><span class="new">Trap-101</span></li>
<li><span class="new">UFP-101</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>β-Casomorphins</li>
<li>Amidorphin</li>
<li><span class="new">BAM-20P</span></li>
<li>Cytochrophin-4</li>
<li><span class="new">Deprolorphin</span></li>
<li>Gliadorphin (gluteomorphin)</li>
<li>Gluten exorphins</li>
<li>Hemorphins</li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a> constituents</li>
<li><span class="new">MEAGL</span></li>
<li><span class="new">MEAP</span></li>
<li><a href="N-Ethylmaleimide.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Ethylmaleimide" title="N-Ethylmaleimide">NEM</a></li>
<li>Neoendorphins</li>
<li>Nepetalactone (catnip)</li>
<li><span class="new">Peptide B</span></li>
<li><span class="new">Peptide E</span></li>
<li><span class="new">Peptide F</span></li>
<li><span class="new">Peptide I</span></li>
<li>Rubiscolins</li>
<li><span class="new">Soymorphins</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Enkephalinase inhibitors:</i> Amastatin</li>
<li><span class="new">BL-2401</span></li>
<li><a href="Candoxatril.htm" tppabs="https://ptable.com/wiki/compounds/A/Candoxatril" title="Candoxatril">Candoxatril</a></li>
<li><a href="Phenylalanine.htm#D-,_L-_and_DL-phenylalanine" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine#D-,_L-_and_DL-phenylalanine" title="Phenylalanine"><span style="font-size:90%;">D </span>-Phenylalanine</a></li>
<li><span class="new">Dexecadotril (retorphan)</span></li>
<li>Ecadotril (sinorphan)</li>
<li>Kelatorphan</li>
<li><a href="Racecadotril.htm" tppabs="https://ptable.com/wiki/compounds/A/Racecadotril" title="Racecadotril">Racecadotril (acetorphan)</a></li>
<li>RB-101</li>
<li>RB-120</li>
<li>RB-3007</li>
<li><span class="new">Opiorphan</span></li>
<li>Selank</li>
<li>Semax</li>
<li>Spinorphin</li>
<li><a href="Thiorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiorphan" title="Thiorphan">Thiorphan</a></li>
<li>Tynorphin</li>
<li><a href="Ubenimex.htm" tppabs="https://ptable.com/wiki/compounds/A/Ubenimex" title="Ubenimex">Ubenimex (bestatin)</a></li></ul>

<ul><li><i>Propeptides:</i> β-Lipotropin (proendorphin)</li>
<li>Prodynorphin</li>
<li>Proenkephalin</li>
<li><span class="new">Pronociceptin</span></li>
<li>Proopiomelanocortin (POMC)</li></ul>

<ul><li><i>Others:</i> Kyotorphin (met-enkephalin releaser/degradation stabilizer)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Signaling peptide/protein receptor modulators</i></div></td></tr></tbody></table></div>












<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-13" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Naltrexone&oldid=972619348  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Naltrexone&oldid=972619348'" tppabs="https://en.wikipedia.org/wiki/?title=Naltrexone&oldid=972619348">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>